Megakaryon

Megakaryon develops platelet products manufactured from induced pluripotent stem (iPS) cells to provide a stable, donation-independent source for transfusion medicine. The company engineers protocols and scalable manufacturing techniques to produce safe, low-cost platelets for clinical transfusion and related cell-therapeutic applications. Megakaryon collaborates with academic institutions and industry partners to advance clinical translation and supply hospitals and blood services domestically and internationally.